CVS-Aetna augurs new health care experience
The pending $69 billion acquisition of Aetna by CVS could yield valuable lessons for others in the health care and drugstore sectors as they seek to forge stronger ties to consumers.
Opinion
What Millennial shoppers want is within reach of retailers
Millennials have been a hot topic of conversation for more than a decade. It’s the one generational group that continues to confound both employers and retailers: How do we attract them, engage them and retain them? Yet a majority of employees and shoppers are them.
Drug chains could benefit from ubiquity of AI
It sounds like a science fiction plot: machines and computers operating with intelligent and human-like behavior. But artificial intelligence (AI) is real and relevant to any task involving the intellect, and AI applications affect nearly all aspects of modern human life.
Walgreens rebranding embraces old, new
In an era when brand image all too often oversells what it is supposed to represent, Walgreens finds itself in the enviable position of updating its identity to better reflect its very real merits and the combination of continuity and change that characterizes the drug chain.
Innovators drive expansion of health categories
New categories can develop when product innovation meets a consumer’s unmet need in a way that no existing category has provided. Retailers that adopt a new category or subcategory early can gain an edge over their competitors. Emerging retail categories disrupt and change the retail market.
Independent drug stores hold their own in Rx market
More often than not, independent drug stores are overshadowed by the big retail chains.
Health@250: America at a crossroads
The impact of a healthy population and vibrant workforce on the ability of the economy to sustain growth should not be underestimated.
NASP hails House action on retroactive Part D fees
The National Association of Specialty Pharmacy (NASP) has commended 54 members of the House of Representatives for urging federal agencies to eliminate retroactive Medicare Part D fees charged by big pharmacy benefit managers.
Retail Rx gets out ahead of Amazon
Speculation about the possible entry of Amazon into the prescription drug business has been abundant in recent weeks.
Consumers@250: Future of chain drug retailing
at least at times — might appear to be the disruptive chaos of today’s market.
Boots adapts its strategy with Farmacias Benavides
To quote one of Cortes’ officers when the Spanish first arrived in Mexico, they came “to serve God and His Majesty and also to get riches.” While the Boots/Walgreens story was playing out in the U.S.
Chain drug industry looks ahead at uncertain future
as much for the uncertainty of the future as for the problems of the past. As November ended and December began, the National Association of Chain Drug Stores brought industry leaders together in New York City for NACDS Week in
Value of NACDS evident as new era dawns
At the start of the month the National Association of Chain Drug Stores concluded a series of successful events in the nation’s economic and cultural capital.
In Rx, ounce of prevention worth pound of cure
A regulatory inspection by the Drug Enforcement Administration or a state board of pharmacy can be a high stakes event.
Old retailing order gives way to new future
As the year nears its end, surprises continue to make news in chain drug retailing. Mostly, negative surprises. Earlier this month, CVS downsized its headquarters staff by some 600 employees, stopping for a moment the retailer’s uninterrupted string of good news.